drugset / Trial / NCT00809848
Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study will evaluate the safety and efficacy of AGN-210669 ophthalmic solution in comparison with AGN-210669 vehicle and bimatoprost ophthalmic solution dosed once-daily each morning, in subjects with ocular hypertension or primary open-angle glaucoma. Subjects will be followed for 2 weeks.
Timeline
- Start
- 2009-02
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bimatoprost | Other / unclassified | 0.03 % | — |
| Subject | SIMENEPAG ISOPROPYL | Small molecule | 0.025 % | — |
| Subject | SIMENEPAG ISOPROPYL | Small molecule | 0.05 % | — |
| Subject | SIMENEPAG ISOPROPYL | Small molecule | 0.075 % | — |